Legend Biotech Corporation
LEGN
Rang în acțiuni
#4472
Legend Biotech Corporation, through its subsidiaries, operates as a... Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Preț acțiune
$18.66
Capitalizare de piață
$3.45B
Schimbare (1 zi)
0.98%
Schimbare (1 an)
-41.61%
Țară
US
Tranzacționează Legend Biotech Corporation (LEGN)
Categorie
Healthcare
EPS pentru Legend Biotech Corporation (LEGN)
EPS la data de June 2026 TTM: $-0.50
Conform celor mai recente rapoarte financiare și prețului acțiunilor Legend Biotech Corporation, EPS-ul actual al companiei (TTM) este $-0.50. La sfârșitul anului 2023, compania avea un EPS de $-5.88 o creștere față de EPS-ului din 2022, care a fost de $-5.62.
Istoricul EPS pentru Legend Biotech Corporation din 2017 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-0.50 | -74.23% |
| 2024 | $-1.94 | -67.01% |
| 2023 | $-5.88 | 4.63% |
| 2022 | $-5.62 | 2.55% |
| 2021 | $-5.48 | 6.61% |
| 2020 | $-5.14 | 154.46% |
| 2019 | $-2.02 | 3,533.09% |
| 2018 | $-0.06 | -139.71% |
| 2017 | $0.14 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | -3,564.00% |
US
|
|
| $-7.98 | 1,496.00% |
US
|
|
| $-5.29 | 958.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -5,648.00% |
NL
|
